MIMS CDS footer logo
  • Home
  • Solutions
    • MIMS Integrated
    • eMIMSplus
  • Practices
    • Hospitals
    • Pharmacies
    • Clinics
    • Telemedicine
    • Become A Partner
  • Learn More
    • Editorial Process
    • Testimonials
    • FAQs
    • Contact Support
  • Blog
  • CONTACT US

From Errors to Efficiency: Why Hospitals Can’t Afford to Skip Medication Safety

by MIMS CDS Asia | Nov 26, 2025 | Wai Fun Leong

5 minutes read time Medication safety underpins every phase of patient treatment. Yet without modern digital infrastructure, hospitals continue to face avoidable mistakes that place patients at risk and inflate operational costs. Medication-related clinical decision...

Clinically Significant Drug Interactions with Grapefruit: What Prescribers Need to Know

by MIMS CDS Asia | Nov 10, 2025 | Ko Keng Kiat

4 minutes read time Grapefruit is often praised for its nutritional value, but for patients on certain medications, this seemingly harmless fruit may pose an avoidable risk. Although grapefruit-drug interactions are well-documented in literature, these risks remain...

Polypharmacy and Hyperglycaemia Risk in Patients with Diabetes

by MIMS CDS Asia | Sep 22, 2025 | Ian Lim

6 minutes read time Type 2 diabetes mellitus (T2DM) is a progressive metabolic disorder characterised by chronic hyperglycaemia resulting from a combination of insulin resistance and impaired insulin secretion. Management of T2DM commonly involves lifestyle...

Implementing Clinical Decision Support System (CDSS): A Path to Success

by MIMS CDS Asia | Sep 8, 2025 | Wai Fun Leong

5 minutes read time CDSS (Clinical Decision Support System) have become indispensable tools in today’s evolving healthcare landscape, helping improve patient care, reduce errors, and enhance outcomes. This article outlines the key steps healthcare organisations should...

Paracetamol Use in NSAID-Allergic Patients – Are You Overlooking the Cross-Sensitivity Risk?

by MIMS CDS Asia | Aug 4, 2025 | Denise Goh

5 minutes read time Paracetamol is widely used and often assumed to be a safe alternative in patients with nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity. However, emerging evidence indicates that cross-reactivity between paracetamol and NSAIDs can occur...
« Older Entries

Recent Posts

  • From Errors to Efficiency: Why Hospitals Can’t Afford to Skip Medication Safety
  • Clinically Significant Drug Interactions with Grapefruit: What Prescribers Need to Know
  • Polypharmacy and Hyperglycaemia Risk in Patients with Diabetes
  • Implementing Clinical Decision Support System (CDSS): A Path to Success
  • Paracetamol Use in NSAID-Allergic Patients – Are You Overlooking the Cross-Sensitivity Risk?
MIMS CDS footer logo

Safer Medications, Better Care.

  • Follow
  • Follow
Navigate
Solutions
– MIMS Integrated
– eMIMSplus
Hospitals
Pharmacies
Clinics
Blog
Editorial Process
Testimonials
FAQs
Become a Partner
Contact Us
Get In Touch


Sales

cdssales@mims.com



Support

cdssupport@mims.com



Regional Headquarters

438B Alexandra Rd, Alexandra Technopark, #06-11 Singapore 119968
Copyright © 2025 MIMS CDS Asia | Privacy Policy